IRIS
CODULLO, VERONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.221
AS - Asia 1.357
EU - Europa 1.283
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 75
OC - Oceania 5
Totale 5.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.140
CN - Cina 525
SG - Singapore 345
IE - Irlanda 253
DE - Germania 231
BR - Brasile 166
RU - Federazione Russa 166
VN - Vietnam 145
HK - Hong Kong 143
FI - Finlandia 141
IT - Italia 129
FR - Francia 73
GB - Regno Unito 63
AT - Austria 60
BD - Bangladesh 55
IN - India 47
ZA - Sudafrica 44
UA - Ucraina 41
CA - Canada 39
SE - Svezia 34
AR - Argentina 21
JP - Giappone 21
NL - Olanda 17
IQ - Iraq 14
PL - Polonia 14
CO - Colombia 12
EC - Ecuador 12
CZ - Repubblica Ceca 11
ES - Italia 10
MA - Marocco 10
SA - Arabia Saudita 9
BE - Belgio 8
MX - Messico 8
VE - Venezuela 8
MY - Malesia 7
UZ - Uzbekistan 7
ID - Indonesia 6
JM - Giamaica 6
BO - Bolivia 5
HN - Honduras 5
KE - Kenya 5
KR - Corea 5
CL - Cile 4
IL - Israele 4
MK - Macedonia 4
PK - Pakistan 4
SV - El Salvador 4
TN - Tunisia 4
TR - Turchia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LT - Lituania 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
MU - Mauritius 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.178
Salva come PNG Salva come JPEG
Città #
San Jose 258
Dublin 248
Chandler 227
Singapore 193
Ashburn 192
Dallas 155
Hong Kong 141
Munich 141
Council Bluffs 123
Beijing 121
Helsinki 85
Nanjing 84
Jacksonville 72
Los Angeles 61
Boardman 53
Vienna 53
New York 51
Ho Chi Minh City 47
Lauterbourg 44
Princeton 39
Johannesburg 38
Lawrence 35
Nanchang 34
Shanghai 32
Hanoi 28
Medford 28
Shenyang 27
São Paulo 27
Buffalo 26
Moscow 26
Wilmington 24
Milan 23
Orem 23
Pavia 23
Santa Clara 22
Turku 22
Tokyo 20
Seattle 18
Jiaxing 17
Changsha 15
Hebei 14
Hangzhou 13
London 13
Redondo Beach 13
Ann Arbor 12
Chennai 12
Columbus 12
Montreal 12
Phoenix 12
Warsaw 12
Chicago 11
Denver 11
Amsterdam 10
Brooklyn 10
Da Nang 10
Poplar 10
Atlanta 9
Brno 9
Haiphong 9
Houston 9
San Francisco 9
The Dalles 9
Toronto 9
Boston 8
Brussels 8
Frankfurt am Main 8
Naples 8
North Bergen 8
Rio de Janeiro 8
Rome 8
Tianjin 8
Woodbridge 8
Falkenstein 7
Manchester 7
Norwalk 7
Pune 7
Stockholm 7
Baghdad 6
Dhaka 6
Fairfield 6
Tashkent 6
Washington 6
Brasília 5
Guangzhou 5
Jyväskylä 5
Mumbai 5
Nuremberg 5
Queens 5
Turin 5
Zhengzhou 5
Biên Hòa 4
Charlotte 4
Düsseldorf 4
Guayaquil 4
La Paz 4
Las Vegas 4
Medellín 4
Mexico City 4
Paris 4
Philadelphia 4
Totale 3.363
Salva come PNG Salva come JPEG
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 284
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 165
B cells in rheumatoid arthritis. 164
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 163
Disease-related malnutrition in systemic sclerosis: Evidences and implications 146
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 145
Antinuclear antibodies in systemic sclerosis 144
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 143
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 138
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 133
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 133
B cells in rheumatoid arthritis. 130
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 127
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 122
Fetal programming and systemic sclerosis 118
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 117
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 116
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 116
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 114
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 110
Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis 108
A 28-Year-Old Man with Stridor and Dyspnea 106
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 102
Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability 101
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. 100
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 98
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials 98
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 98
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 98
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 97
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 97
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 96
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 95
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 94
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 92
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis 92
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 91
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 88
Pathophysiology of systemic sclerosis 88
Stress doppler echocardiography in systemic sclerosis: Evidence for a role in the prediction of pulmonary hypertension 88
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 83
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 83
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway 82
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 78
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience 72
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 49
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 47
Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts 17
Totale 5.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022165 0 0 0 0 0 8 1 6 14 4 26 106
2022/2023688 71 66 12 62 58 68 1 42 273 5 22 8
2023/2024297 34 58 9 15 13 67 13 27 0 22 8 31
2024/2025975 21 45 9 22 15 90 93 81 242 41 102 214
2025/20262.057 147 103 221 227 225 114 329 106 201 140 93 151
2026/2027489 40 86 105 179 79 0 0 0 0 0 0 0
Totale 5.266